Biodiversity crisis: Why agriculture threatens biodiversity, and how responsible investors can respond

  • 02 September 2020
  • 5 min read

Executive summary

  • Biodiversity plays a crucial role in protecting our health. It is only by understanding and respecting its limits that we will maintain the ecosystems that ensure our survival.
  • Human activity is a growing threat to our life support system and it is urgent that we strike a better balance. We see the COVID-19 pandemic as a wake-up call.
  • Agricultural production is dependent on the good functioning of ecosystems, but its intensification has led to a sharp degradation of biodiversity – the source of all variety in our crops and livestock. Intensive agriculture and related deforestation can also contribute to the spread of diseases.
  • Soybean production has more than tripled in the past 30 years and it illustrates well how the intensification of agriculture and global commodity trading can create threats for nature.
  • Many companies in the agricultural value chain may directly or indirectly benefit from the capital we provide to the market, but we have identified two particular types of companies to engage with: global traders and consumer facing companies. We consider they can influence many other players in the value chain.
  • From traders to consumer facing companies, corporates must promote responsible agricultural practices and provide stakeholders with the necessary transparency from field to shelf.
  • This research piece follows on from a primer on the broader topic we published last year. The piece can be found here.

    Not for Retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date.

    All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document. Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.

    Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales, No: 01431068. Registered Office: 22 Bishopsgate, London, EC2N 4BQ. In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.